SSO 2022 Press Release – Preliminary Results of a Phase ib/2 Window of Opportunity Clinical Trial (NCT04454528) Assessing the Effects of Preoperative (preop) Pembrolizumab +/- radiation in Early-stage Breast Cancer (eBC)
Julia Tchou, MD PhD (Presenter;Submitter) – University of Pennsylvannia; INTRODUCTION: Immune checkpoint inhibition (ICI) is currently only used in combination with chemotherapy in breast cancer